Fig 1.
Properties of mutant K-RAS revealed by analysis of isogenic human CRC cell line pairs. Oncogenic K-RAS engages both pro-tumorigenic pathways (shaded in blue) and, paradoxically, anti-tumorigenic pathways (shaded in red). Arrows represent both direct and indirect interactions.